Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Discovery may allow more selective chemokine targeting

April 6, 2022

AIMer RNA base editing oligonucleotides edit ACTB transcript in the liver of nonhuman primates

April 4, 2022

Telomere to telomere, the human genome is done

April 1, 2022

LNP formulation development and production service launched by eTheRNA Manufacturing

March 29, 2022

Insilico Medicine and EQRx enter drug discovery and development collaboration

March 25, 2022

BiondVax collaborates with Max Planck and UMG for development of NanoAbs

March 25, 2022

Chugai gains access to Halozyme's ENHANZE drug delivery technology

March 25, 2022

LifeMine and GSK establish strategic R&D collaboration

March 23, 2022

Spotlight Therapeutics to advance cell-targeted in vivo CRISPR gene editing biologics

March 23, 2022

Prellis and Sanofi collaborate on discovery of antibodies

March 23, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...